News

World Cancer Day - Because every patient deserves optimal treatment

4 February 2021

The Anticancer Fund supports EORTC trial in oligometastatic rare cancers with Rising Tide Foundation

2 February 2021

First patient in EORTC's trial for retroperitoneal sarcoma

21 January 2021

Study in pancreatic cancer improved survival rate of mice

8 January 2021

Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study

Christoffer Gebhardt, Sonja C S Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal. Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular Immunology, 2021 Feb;360:104274, doi: 10.1016/j.cellimm.2020.104274

28 December 2020

The MATAO trial for ovarian cancer patients is open for participation

11 December 2020